CD8 T细胞与自然杀伤细胞：免疫治疗的并行且互补的“战士”
CD8 T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy.
作者信息
Rosenberg Jillian, Huang Jun
机构信息
Committee on Cancer Biology, The University of Chicago, IL 60637, USA.
Institute for Molecular Engineering, The University of Chicago, IL 60637, USA.
出版信息
Curr Opin Chem Eng. 2018 Mar;19:9-20. doi: 10.1016/j.coche.2017.11.006. Epub 2017 Dec 14.
Abstract
CD8 T cells and NK cells are both cytotoxic effector cells of the immune system, but the recognition, specificity, sensitivity, and memory mechanisms are drastically different. While many of these topics have been extensively studied in CD8 T cells, very little is known about NK cells. Current cancer immunotherapies mainly focus on CD8 T cells, but have many issues of toxicity and efficacy. Given the heterogeneous nature of cancer, personalized cancer immunotherapy that integrates the power of both CD8 T cells in adaptive immunity and NK cells in innate immunity might be the future direction, along with precision targeting and effective delivery of tumor-specific, memory CD8 T cells and NK cells.
摘要
CD8 T细胞和自然杀伤（NK）细胞都是免疫系统的细胞毒性效应细胞，但它们的识别、特异性、敏感性和记忆机制却大不相同。虽然其中许多主题已在CD8 T细胞中得到广泛研究，但关于NK细胞的了解却非常少。目前的癌症免疫疗法主要集中在CD8 T细胞上，但存在许多毒性和疗效问题。鉴于癌症的异质性，整合适应性免疫中的CD8 T细胞和先天性免疫中的NK细胞的个性化癌症免疫疗法可能是未来的方向，同时还需要精准靶向和有效递送肿瘤特异性记忆CD8 T细胞和NK细胞。
相似文献
1
CD8 T Cells and NK Cells: Parallel and Complementary Soldiers of Immunotherapy.CD8 T细胞与自然杀伤细胞：免疫治疗的并行且互补的“战士”
Curr Opin Chem Eng. 2018 Mar;19:9-20. doi: 10.1016/j.coche.2017.11.006. Epub 2017 Dec 14.
2
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8 T cells against tumor.癌症疫苗与 CD122 偏向性 IL-2/抗 IL-2 Ab 复合物联合塑造针对肿瘤的类干细胞效应 NK 和 CD8 T 细胞。
J Immunother Cancer. 2023 Jul;11(7). doi: 10.1136/jitc-2022-006409.
3
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.呼肠孤病毒诱导的细胞免疫治疗多发性骨髓瘤在耐药骨髓微环境中的作用。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001803.
4
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞：综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.
5
The Development of Chiral Nanoparticles to Target NK Cells and CD8 T Cells for Cancer Immunotherapy.用于癌症免疫治疗的靶向自然杀伤细胞和CD8 T细胞的手性纳米颗粒的研发
Adv Mater. 2022 Apr;34(16):e2109354. doi: 10.1002/adma.202109354. Epub 2022 Mar 10.
6
Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.自然杀伤细胞：癌症免疫治疗成功的关键。
Front Immunol. 2021 Apr 28;12:679117. doi: 10.3389/fimmu.2021.679117. eCollection 2021.
7
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.锰通过 cGAS-STING 对抗肿瘤免疫反应至关重要，并提高了临床免疫疗法的疗效。
Cell Res. 2020 Nov;30(11):966-979. doi: 10.1038/s41422-020-00395-4. Epub 2020 Aug 24.
8
β-Adrenergic Signaling Impairs Antitumor CD8 T-cell Responses to B-cell Lymphoma Immunotherapy.β-肾上腺素能信号会损害抗肿瘤 CD8 T 细胞对 B 细胞淋巴瘤免疫治疗的反应。
Cancer Immunol Res. 2018 Jan;6(1):98-109. doi: 10.1158/2326-6066.CIR-17-0401. Epub 2017 Nov 16.
9
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer.自然杀伤细胞和细胞毒性T细胞：对抗微生物和癌症的互补伙伴。
Microorganisms. 2024 Jan 22;12(1):230. doi: 10.3390/microorganisms12010230.
10
Pharmacological targeting of natural killer cells for cancer immunotherapy.自然杀伤细胞的药理学靶向在癌症免疫治疗中的应用。
Cancer Sci. 2020 Jun;111(6):1869-1875. doi: 10.1111/cas.14418. Epub 2020 May 5.
引用本文的文献
1
Fragment-Based Immune Cell Engager Antibodies in Treatment of Cancer, Infectious and Autoimmune Diseases: Lessons and Insights from Clinical and Translational Studies.基于片段的免疫细胞衔接抗体在癌症、感染性疾病和自身免疫性疾病治疗中的应用：临床和转化研究的经验与见解
Antibodies (Basel). 2025 Jun 24;14(3):52. doi: 10.3390/antib14030052.
2
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.头颈部癌症中临床相关基因融合的患病率及生物学影响
NPJ Precis Oncol. 2025 Jul 3;9(1):221. doi: 10.1038/s41698-025-00889-7.
3
HAPIR: a refined Hallmark gene set-based machine learning approach for predicting immunotherapy response in cancer patients.HAPIR：一种基于改进的标志性基因集的机器学习方法，用于预测癌症患者的免疫治疗反应。
NPJ Precis Oncol. 2025 Jun 18;9(1):194. doi: 10.1038/s41698-025-00992-9.
4
Tumor hypoxia shapes natural killer cell anticancer activities.肿瘤缺氧塑造自然杀伤细胞的抗癌活性。
J Mol Med (Berl). 2025 May 30. doi: 10.1007/s00109-025-02557-6.
5
Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and Management.系统性硬化症与原发性胆汁性胆管炎：对两种重叠罕见疾病的综合综述及诊断与管理见解
Cureus. 2025 Apr 10;17(4):e82008. doi: 10.7759/cureus.82008. eCollection 2025 Apr.
6
A CDKN2B-Associated Immune Prognostic Model for Predicting Immune Cell Infiltration and Prognosis in Esophageal Carcinoma.一种用于预测食管癌免疫细胞浸润和预后的CDKN2B相关免疫预后模型。
Clin Exp Gastroenterol. 2025 Apr 18;18:41-54. doi: 10.2147/CEG.S510078. eCollection 2025.
7
Single-Cell Transcriptomic Analysis of Kaposi Sarcoma.卡波西肉瘤的单细胞转录组分析
PLoS Pathog. 2025 Apr 1;21(4):e1012233. doi: 10.1371/journal.ppat.1012233. eCollection 2025 Apr.
8
Efficient count-based models improve power and robustness for large-scale single-cell eQTL mapping.基于计数的高效模型提高了大规模单细胞eQTL定位的效能和稳健性。
medRxiv. 2025 Mar 5:2025.01.18.25320755. doi: 10.1101/2025.01.18.25320755.
9
Small-diameter artery grafts engineered from pluripotent stem cells maintain 100% patency in an allogeneic rhesus macaque model.由多能干细胞构建的小口径动脉移植物在同种异体恒河猴模型中保持100%通畅。
Cell Rep Med. 2025 Mar 18;6(3):102002. doi: 10.1016/j.xcrm.2025.102002. Epub 2025 Mar 10.
10
HLA-B*58 and HLA-C*2 Alleles Are Associated with the Occurrence of Rheumatoid Arthritis Among Omanis.HLA - B*58和HLA - C*2等位基因与阿曼人群类风湿关节炎的发生相关。
J Clin Med. 2025 Feb 13;14(4):1219. doi: 10.3390/jcm14041219.
本文引用的文献
1
The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma.食管和胃腺癌中肿瘤浸润性T淋巴细胞和NK细胞与B淋巴细胞及浆细胞密度的综合临床影响
Oncotarget. 2017 Jul 21;8(42):72108-72126. doi: 10.18632/oncotarget.19437. eCollection 2017 Sep 22.
2
Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia.CTL019在复发/难治性B细胞急性淋巴细胞白血病和慢性淋巴细胞白血病中的细胞动力学
Blood. 2017 Nov 23;130(21):2317-2325. doi: 10.1182/blood-2017-06-786129. Epub 2017 Sep 21.
3
Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.嵌合抗原受体（CAR）修饰的自然杀伤细胞在肿瘤免疫治疗中的作用。
Acta Pharmacol Sin. 2018 Feb;39(2):167-176. doi: 10.1038/aps.2017.125. Epub 2017 Sep 7.
4
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.用于治疗 ErbB2 阳性恶性肿瘤的基因修饰、CAR 表达 NK-92 细胞的临床级制造。
Cancer Immunol Immunother. 2018 Jan;67(1):25-38. doi: 10.1007/s00262-017-2055-2. Epub 2017 Sep 6.
5
Equipping NK Cells with CARs.为自然杀伤（NK）细胞配备嵌合抗原受体（CAR）。
Cancer Discov. 2017 Oct;7(10):OF2. doi: 10.1158/2159-8290.CD-NB2017-124. Epub 2017 Sep 6.
6
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.效应 NK 细胞向 1 型先天淋巴样细胞的转化导致肿瘤免疫逃逸。
Nat Immunol. 2017 Sep;18(9):1004-1015. doi: 10.1038/ni.3800. Epub 2017 Jul 31.
7
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.经基因工程改造表达 IL-15 和靶向 CD19 的 CAR 的脐血 NK 细胞具有长期持久性和强大的抗肿瘤活性。
Leukemia. 2018 Feb;32(2):520-531. doi: 10.1038/leu.2017.226. Epub 2017 Jul 20.
8
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.表达 MIC-A 的单核细胞增强自然杀伤细胞 Fc 受体介导的抗肿瘤功能。
Cancer Immunol Res. 2017 Sep;5(9):778-789. doi: 10.1158/2326-6066.CIR-16-0005. Epub 2017 Jul 19.
9
Engineering Natural Killer Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化自然杀伤细胞
Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28.
10
The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.肺癌的免疫检查点阻断治疗时代：松开免疫系统的刹车。
Ann Am Thorac Soc. 2017 Aug;14(8):1248-1260. doi: 10.1513/AnnalsATS.201702-152FR.
Zotero 插件